ABRILADA
Biological
PFIZER INC.
Total Payments
$55,678
Transactions
41
Doctors
33
Companies
2
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $6,484 | 9 | 9 |
| 2023 | $49,193 | 32 | 24 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $31,615 | 11 | 56.8% |
| Unspecified | $16,000 | 5 | 28.7% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $7,400 | 2 | 13.3% |
| Food and Beverage | $662.50 | 23 | 1.2% |
Payments by Type
General
$39,678
36 transactions
Research
$16,000
5 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| ADALIMUMAB PFIZER CLINICAL PUBLICATION PROGRAM | PFIZER INC. | $16,000 | 5 |
Top Doctors Receiving Payments for ABRILADA — Page 2
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , M.D | Obstetrics & Gynecology | Grand Rapids, MI | $19.00 | 1 |
| , MD | Gastroenterology | Missoula, MT | $19.00 | 1 |
| , M.D | Obstetrics & Gynecology | Grand Rapids, MI | $19.00 | 1 |
| , WHNP-BC | Women's Health | Grand Rapids, MI | $19.00 | 1 |
| , M.D | Family Medicine | Indianapolis, IN | $15.28 | 1 |
| , MD | Family Medicine | Indianapolis, IN | $15.28 | 1 |
| , PA-C | Physician Assistant | Indianapolis, IN | $15.28 | 1 |
| , FNP | Family | New Hartford, NY | $11.36 | 1 |
Ad
Manufacturing Companies
- PFIZER INC. $43,868
- WHITEHALL INTERNATIONAL INC $11,810
Product Information
- Type Biological
- Total Payments $55,678
- Total Doctors 33
- Transactions 41
About ABRILADA
ABRILADA is a biological associated with $55,678 in payments to 33 healthcare providers, recorded across 41 transactions in the CMS Open Payments database. The primary manufacturer is PFIZER INC..
Payment data is available from 2023 to 2024. In 2024, $6,484 was paid across 9 transactions to 9 doctors.
The most common payment nature for ABRILADA is "Consulting Fee" ($31,615, 56.8% of total).
ABRILADA is associated with 1 research study, including "ADALIMUMAB PFIZER CLINICAL PUBLICATION PROGRAM" ($16,000).